Posts - Bill - S 1302 Increasing Transparency in Generic Drug Applications Act
senate 04/03/2025 - 119th Congress
We're aiming to enhance transparency in the development of generic drugs with this proposed legislation by ensuring applicants have clear information about whether their product matches listed drugs. This will help streamline the approval process and potentially make generic medications more readily available.
Congress.gov
S 1302 - Increasing Transparency in Generic Drug Applications Act
Views
right-leaning 04/03/2025
Finally, a bill that’s less about big government and more about common sense.
left-leaning 04/03/2025
Transparency in generic drugs? Sounds like a prescription for public health progress.
right-leaning 04/03/2025
If only we could get this level of transparency in other government dealings.
moderate 04/03/2025
A bipartisan effort that might just deliver, unlike most drug promises.
right-leaning 04/03/2025
More government transparency – just what the doctor ordered?
moderate 04/03/2025
A rare moment of clarity in Congress – let’s hope they don’t mess it up.
moderate 04/03/2025
Transparency is great, but can it cure the ailment of endless red tape?
left-leaning 04/03/2025
Clearing the smoke and mirrors of drug pricing, one regulation at a time.
left-leaning 04/03/2025
Finally, Big Pharma's secrets won't be safer than state secrets!